Teladoc Health (TDOC) Projected to Release Earnings on Tuesday

Teladoc Health (NYSE:TDOCGet Free Report) will likely be posting its quarterly earnings results before the market opens on Tuesday, February 18th. Analysts expect Teladoc Health to post earnings of ($0.21) per share and revenue of $639.44 million for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $13.86 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a one year low of $6.76 and a one year high of $21.74. The firm has a market capitalization of $2.39 billion, a price-to-earnings ratio of -2.40 and a beta of 1.05. The company has a 50 day moving average price of $10.09 and a 200 day moving average price of $9.17.

Wall Street Analysts Forecast Growth

TDOC has been the subject of a number of recent analyst reports. Piper Sandler reissued an “overweight” rating and issued a $13.00 price objective (up from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Royal Bank of Canada raised their target price on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. The Goldman Sachs Group assumed coverage on Teladoc Health in a research report on Friday, November 15th. They issued a “buy” rating and a $14.00 target price on the stock. Finally, Barclays boosted their price target on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Fourteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $11.97.

View Our Latest Report on TDOC

Insider Transactions at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Read More

Earnings History for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.